Skip to main content

and
  1. No Access

    Article

    Serum Survivin in Oral Submucosal Fibrosis and Squamous Cell Carcinoma

    Survivin, an inhibitor of apoptosis protein is a biomarker of significance in prognostication of many malignancies. In the current study we investigated the serum survivin levels in patients with oral submucos...

    Ramya Thota, Sadhna Aggarwal in Indian Journal of Otolaryngology and Head … (2022)

  2. Article

    Open Access

    An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy

    Over half of colorectal cancers (CRCs) are hard-wired to RAS/RAF/MEK/ERK pathway oncogenic signaling. However, the promise of targeted therapeutic inhibitors, has been tempered by disappointing clinical activi...

    Mingli Yang, Thomas B. Davis, Lance Pflieger, Michael V. Nebozhyn in BMC Cancer (2022)

  3. Article

    Open Access

    Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors

    Long-acting somatostatin analogs (LA SSAs) are approved and recommended for the treatment of patients with advanced neuroendocrine tumors (NETs). Given the long duration of therapy and differences in administr...

    Christina Darden, Mark Price, David Ray in Journal of Patient-Reported Outcomes (2021)

  4. Article

    Open Access

    Differential methylation of G-protein coupled receptor signaling genes in gastrointestinal neuroendocrine tumors

    Neuroendocrine tumors (NETs) of the small intestine undergo large chromosomal and methylation changes. The objective of this study was to identify methylation differences in NETs and consider how the different...

    Seyoun Byun, Kajsa E. Affolter, Angela K. Snow, Karen Curtin in Scientific Reports (2021)

  5. No Access

    Article

    Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

    The Targeted Agent and Profiling Utilization Registry (TAPUR) Study, a phase II basket study, evaluates anti-tumor activity of commercially available targeted agents in patients with advanced cancers harboring...

    Julie G. Fisher, David Tait, Elizabeth Garrett-Mayer, Susan Halabi in Targeted Oncology (2020)

  6. No Access

    Article

    Low-Grade Fibromyxoid Sarcoma of the External Auditory Canal: A Rare Pathology and Unusual Location

    Low-grade fibromyxoid sarcoma (LGFMS) is an enigmatic soft tissue tumor. It frequently presents as a deeply seated mass in the proximal extremities and trunk. Superficial LGFMSs of the head and neck are exceed...

    Kalpana Kumari, Ramya Thota, Heera Lal Chaudhary in Head and Neck Pathology (2020)

  7. No Access

    Article

    Systemic amyloidosis masquerading as iron deficiency anemia

    Ramya Thota, Wilson Gonsalves, Tsewang Tashi in Indian Journal of Gastroenterology (2012)

  8. No Access

    Article

    Apparent heparin resistance in a patient with infective endocarditis secondary to elevated factor VIII levels

    Heparin resistance (HR) is defined as increasing requirements of heparin to maintain a therapeutic activated partial thromboplastin time (aPTT). It is commonly associated with antithrombin deficiency, increase...

    Ramya Thota, Apar Kishor Ganti, Shanmuga Subbiah in Journal of Thrombosis and Thrombolysis (2012)

  9. No Access

    Article

    Hemodynamic collapse following bilateral knee arthroplasty: a mysterious case

    Severe hemodynamic collapse after knee surgery from bilateral adrenal hemorrhages is rare. Even rarer is it occurring from adrenal hemorrhage as a complication of heparin induced thrombocytopenia. Due to lack ...

    Ramya Thota, Joann Porter, Apar K. Ganti in Journal of Thrombosis and Thrombolysis (2012)